Dr. Xueting Liu 2011.7- The Second Affiliated Hospital of Guangzhou Medical University, assistant professor; 2015.4-2016.6, Washington University School of Medicine, postdoctoral training; 2008.9-2011.6, Jinan University, Biochemistry and Molecular Biology, Ph.D; 2005.9-2008.6, Jinan University, Genetics, M.S; 2001.9-2005.6, Jinan University, Biotechnology, B.S. My current research interest is trying to intensively investigate the crosstalk between nervous system and immune system associated with chronic inflammatory and autoimmune diseases, i.e. atopic dermatitis, asthma, psoriasis, which will potentially lead to discovery of specific therapies in nearing future. Publications 1. XT Liu,et al, J. Invest. Dermatol.,2021,141(4):863.(IF=7.59) 2. XT Liu,et al, J. Invest. Dermatol.,2020,140(9),1856.(IF=7.59) 3.SS Liu#, XT Liu#,et al, Brain Behav Immun,2019,80,711.(IF=19.227) 4. XT Liu, et al, Asian Pac J Allergy.2020,38(1):52.(IF =7.143) 5.QT Meng#, XY Liu#, XT Liu# ,et al, eLife,2021.10:e71689.(IF=8.713) 6.J Wang#; XT Liu#, et al, Mol Cancer Ther,2011,10(9),1656.(IF=6.261) 7.Y He#, XT Liu #, Mediators of Inflammation,2014,291618,2014.(IF=4.529) 8. XT Liu , et al, Mol and Cellular Biochem.2017,434(1-2), 75.(IF=3.842) 9. XT Liu, et al, Technol Cancer Res Treat.2018,17, 1533033818762910.(IF=2.876) 10.D M. Barry; XT Liu,et al,Nature Communications.2020,11:1397.(IF=17.694) 11. YQ Yu#; DM Barry#; Y Hao#;Xueting Liu,et al, Science,2017,355(6329):1072.(IF=63.714)